CN103408492A - Preparation method of 6-substitute-5,6-dihydro phenanthridine derivative - Google Patents

Preparation method of 6-substitute-5,6-dihydro phenanthridine derivative Download PDF

Info

Publication number
CN103408492A
CN103408492A CN2013103681058A CN201310368105A CN103408492A CN 103408492 A CN103408492 A CN 103408492A CN 2013103681058 A CN2013103681058 A CN 2013103681058A CN 201310368105 A CN201310368105 A CN 201310368105A CN 103408492 A CN103408492 A CN 103408492A
Authority
CN
China
Prior art keywords
preparation
dihydro
catalyzer
alkali
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013103681058A
Other languages
Chinese (zh)
Other versions
CN103408492B (en
Inventor
徐云根
朱启华
姚魏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201310368105.8A priority Critical patent/CN103408492B/en
Publication of CN103408492A publication Critical patent/CN103408492A/en
Application granted granted Critical
Publication of CN103408492B publication Critical patent/CN103408492B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to the field of organic synthesis, and particularly relates to a preparation method of a 6-substitute-5,6-dihydro phenanthridine derivative. The preparation method disclosed by the invention comprises the following steps of: carrying out Suzuki-Miyaura reaction and Michael addition reaction on phenylboronic acid ester II and an o-bromoaniline derivative III which used as raw materials in the presence of a palladium catalyst in a one-pot manner. The method has the advantages of easily available raw material, wide substrate application range, high yield, and the like.

Description

A kind of 6-replaces the preparation method of-5,6-dihydro phenanthridine derivatives
Technical field
The present invention relates to the organic synthesis field.Be specifically related to the preparation method of 6-replacement-5,6-dihydro phenanthridine derivatives.
Background technology
5,6-dihydro phenanthridine derivatives is the mother nucleus structure of multiple natural product, and its derivative has multiple biological activity.Document (Bioorg Med Chem Lett, 2012,22,3095 – 3099) has reported that a class contains the derivative of 5,6-dihydro phenanthridines structure, and finds that they have the bradykinin b 1 receptor antagonistic activity.
Document (J Org Chem, 1998,63,5211-5215) 5 of report, the synthetic route of 6-dihydro phenanthridine derivatives is as follows:
Figure BDA00003695972700011
There is following shortcoming in aforesaid method: the source difficulty of (1) biphenyl derivatives 1; (2) use two kinds of noble metal catalysts.
Summary of the invention
The objective of the invention is to find a kind of with low cost, raw material conveniently is easy to get, eco-friendly preparation 6-replaces-5,6-dihydro phenanthridine derivatives method.
The invention discloses the preparation method that a kind of 6-replaces-5,6-dihydro phenanthridine derivatives (I), comprising:
Figure BDA00003695972700012
Wherein: R 1Alkyl, phenyl, methoxy or ethoxy for C1~C6; R 2For hydrogen, chlorine, fluorine or methyl; R 3For hydrogen or p-toluenesulfonyl;
Catalyzer is tetrakis triphenylphosphine palladium, [1,1 '-bis-(diphenylphosphino) ferrocene] palladium chloride, [1,1 '-bis-(diphenylphosphine) ferrocene] palladium chloride methylene dichloride complex compound, two (bis-Ya Benzyl benzylacetone) palladium or [two (triphenyl phosphorus)] palladium chloride.
The inventive method be take borate ester (II) and o-bromoaniline derivative (III) and is raw material, and Suzuki-Miyaura reaction and Michael addition reaction are carried out to " treating different things alike ", reacts under the existence of catalyzer and alkali.Filter after completion of the reaction, filtrate decompression concentration and recovery organic solvent, (ethyl acetate: sherwood oil=0-10:1) separate obtains I to the residue column chromatography.
The preferred tetrakis triphenylphosphine palladium of catalyzer wherein.
Alkali is preferably from aqueous sodium carbonate, wet chemical, aqueous sodium hydroxide solution, potassium hydroxide aqueous solution, cesium fluoride, potassiumphosphate, DIPEA, 1,8-diazabicyclo [5.4.0] 11 carbon-7-alkene or triethylamine.Alkali is aqueous sodium carbonate or wet chemical more preferably.The concentration of the aqueous solution of above-mentioned alkali is preferably 0.1mol/L~5mol/L; More preferably 1mol/L~3mol/L.
Reaction solvent is glycol dimethyl ether, ethylene glycol diethyl ether, Isosorbide-5-Nitrae-dioxane or DMF.More preferably glycol dimethyl ether.
Preferably 50 ℃~120 ℃ of wherein said temperature of reaction; More preferably 80 ℃~110 ℃.
In present method, the molar ratio of each component is preferred: substrate II: substrate III: catalyzer: alkali=1:0.5~2:0.01~0.2:1~10; More preferably 1:0.9~1.1:0.05~0.1:4~8.
Preparation method of the present invention and document (J Org Chem, 1998,63,5211-5215) compare, have that raw material is easy to get, the substrate wide accommodation, only need a kind of catalyzer, productive rate advantages of higher.
Embodiment
Embodiment 1
6-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-1) synthetic:
Figure BDA00003695972700021
In the 500ml three-necked bottle, by (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) (2.72g, 0.01mol), N-(4-tosyl group)-2-bromaniline (3.24g; 0.01mol), tetrakis triphenylphosphine palladium (1.16g, 0.001mol) and 2mol/L aqueous sodium carbonate (6.36g; 0.06mol) all be dissolved in the 300mL glycol dimethyl ether, pass into nitrogen protection, be heated to the 6h that refluxes; after the TLC monitoring reaction completes, be cooled to room temperature, filter; filtrate decompression is concentrated, and the residue column chromatography for separation, obtain yellow oil product I-1; heavy 2.76g, productive rate 84.9%.
1H-NMR(300MHz,CDCl3)δ7.74(dd,J=7.6,1.4Hz,1H),7.57(dd,J=7.4,1.7Hz,1H),7.43–7.29(m,2H),7.23–7.13(m,2H),7.13–7.02(m,2H),6.88(d,J=8.2Hz,2H),6.65(d?J=8.1Hz,2H),5.82(t,J=7.2Hz,1H),2.67(dd,J=16.1,7.4Hz,1H),2.47(dd,J=16.1,7.1Hz,1H),2.10(s,3H),2.09(s,3H).
13C-NMR(75MHz,CDCl3)δ204.61,142.61,133.82,133.34,132.50,129.51,129.07,128.88,128.82,28.73,128.16,127.88,127.49,127.26,127.21,126.51,126.37,123.13,122.93,54.19,48.37,29.88,20.77.
Embodiment 2
2-methyl-6-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-2) synthetic:
With (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) and 4-methyl-N-(4-tosyl group)-2-bromaniline be raw material, the operation with embodiment 1, obtain yellow oil product I-2, productive rate 92%.
1H-NMR(300MHz,CDCl3)δ7.66(d,J=8.2Hz,1H),7.40(s,1H),7.26–7.17(m,3H),7.16–7.20(m,2H),6.94(d,J=8.3Hz,2H),6.70(d,J=8.0Hz,2H),5.81(t,J=7.2Hz,1H),2.71(dd,J=16.2,7.4Hz,1H),2.50(dd,J=16.1,7.2Hz,1H),2.44(s,3H),2.16(s,3H),2.14(s,3H).
13C-NMR(75MHz,CDCl 3)δ204.61,142.32,137.00,133.89,133.52,130.03,129.37,129.16,129.02,128.75,127.81,127.26,127.04,126.78,126.60,126.45,123.61,122.62,122.02,54.95,48.37,29.88,20.91,20.72.
Embodiment 3
The fluoro-6-of 2-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-3) synthetic:
With (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) and the fluoro-N-of 4-(4-tosyl group)-2-bromaniline be raw material, the operation with embodiment 1, obtain yellow solid product I-3, productive rate 83%, 123~125 ℃ of melting ranges.
1H-NMR(300MHz,CDCl 3)δ7.75(dd,J=8.9,5.3Hz,1H),7.26(dd,J=9.33,3.0Hz,1H),7.21(s,1H),7.19–7.06(m,4H),6.91(d,J=8.3Hz,2H),6.69(d,J=8.0Hz,2H),5.84(t,J=7.2Hz,1H),2.68(dd,J=16.2,7.3Hz,1H),2.50(dd,J=16.2,7.3Hz,1H),2.14(s,3H),2.12(s,3H).
13C-NMR(75MHz,CDCl 3)δ204.10,163.02,159.84,142.70,133.94,133.12,131.42,131.31,130.90,130.77,128.15,127.95,127.28,126.59,122.88,115.28,115.01,109.82,109.51,54.70,48.37,29.31,20.82.
Embodiment 4
6-benzoyl methyl-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-4) synthetic:
Take (E)-2-(3-oxo-3-phenyl propenyl) phenylo boric acid pinacol ester (II-2:R=Ph) and N-(4-tosyl group)-2-bromaniline is raw material; operation is with embodiment 1; obtain white solid product I-4, productive rate 87%, 144~147 ℃ of melting ranges.
Figure BDA00003695972700042
1H-NMR(300MHz,CDCl 3)δ7.76(d,J=1.3Hz,1H),7.73(d,J=1.3Hz,1H),7.65–7.59(m,1H),7.54-7.43(m,2H),7.41–7.33(m,2H),7.30–7.20(m,2H),7.30–7.21(m,2H),7.15–7.04(m,2H),6.95(d,J=8.3Hz,2H),6.69(d,J=8.1Hz,2H),6.08(dd,J=7.9,5.9Hz,1H),3.34(dd,J=16.4,8.1Hz,1H),3.01(dd,J=16.4,8.1Hz,1H),2.14(s,3H).
13C-NMR(75MHz,CDCl 3)δ195.75,142.60,142.37,136.20,134.08,133.73,132.95,132.72,132.12,129.55,128.95,128.91,128.04,128.01,127.93,127.83,127.62,127.35,127.11,127.06,126.88,126.56,126.49,123.07,122.68,54.70,43.30,20.51.
Embodiment 5
2-methyl-6-benzoyl methyl-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-5) synthetic:
Take (E)-2-(3-oxo-3-phenyl propenyl) phenylo boric acid pinacol ester (II-2:R=Ph) and 4-methyl-N-p-toluenesulfonyl-2-bromaniline is raw material; operation is with embodiment 1; obtain faint yellow solid product I-5, productive rate 88%, 131~135 ℃ of melting ranges.
Figure BDA00003695972700051
1H-NMR(300MHz,CDCl 3)δ7.81(d,J=7.7Hz,1H),7.75(d,J=7.8Hz,1H),7.61(d,J=7.9Hz,1H),7.53-7.46(m,2H),7.42–7.35(m,3H),7.24–7.19(m,2H),7.07(m,2H),6.95(d,J=8.0Hz,2H),6.69(d,J=7.9Hz,2H),6.04(t,J=6.9Hz,1H),3.34(dd,J=16.4,5.7Hz,1H),3.00(dd,J=16.3,7.8Hz,1H),2.41(s,3H),2.14(s,3H).
13C-NMR(75MHz,CDCl3)δ195.75,142.23,138.23,136.81,134.10,133.77,132.65,130.38,129.21,129.05,128.91,128.72,128.61,128.00,127.93,127.81,127.65,127.18,127.02,126.97,126.85,126.60,126.50,123.54,122.60,54.63,43.60,20.91,20.71.
Embodiment 6
The fluoro-6-benzoyl of 2-methyl-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-6) synthetic:
Take (E)-2-(3-oxo-3-phenyl propenyl) phenylo boric acid pinacol ester (II-2:R=Ph) and the fluoro-N-of 4-(4-tosyl group)-2-bromaniline is raw material, and operation, with embodiment 1, obtains white solid product I-6,104~107 ℃ of productive rates.
Figure BDA00003695972700052
1H-NMR(300MHz,CDCl 3)δ7.81(d,J=7.3Hz,1H),7.75(d,J=7.5,1H),7.72–7.66(m,1H),7.55–7.45(m,2H),7.40–7.35(m,2H),7.32–7.26(m,2H),7.14–7.08(m,2H),6.94(d,J=8.1Hz,2H),6.70(d,J=8.0Hz,2H),6.08(t,J=6.9Hz,1H),3.33(dd,J=16.4,5.9Hz,1H),3.00(dd,J=16.5,7.9Hz,1H),2.15(s,3H).
13C-NMR(75MHz,CDCl 3)δ195.49,142.58,140.75,134.15,132.90,132.16,130.91,130.79,129.53,129.20,128.08,127.94,127.60,127.25,126.97,126.85,126.58,126.50,123.33,122.90,115.19,114.88,109.88,109.51,54.95,43.91,20.77.
Embodiment 7
6-ethoxycarbonylmethyl group-5-p-toluenesulfonyl-5,6-dihydro phenanthridines (I-7) synthetic:
With (E)-2-(3-oxyethyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-3:R=OCH 2CH 3) and N-(4-tosyl group)-2-bromaniline be raw material, the operation with embodiment 1, obtain white solid product I-7, productive rate 90%, 103~104 ℃ of melting ranges.
Figure BDA00003695972700061
1H-NMR(300MHz,CDCl 3)δ7.77(dd,J=7.8,1.2Hz,1H),7.57(dd,J=7.5,1.5Hz,1H),7.42–7.29(m,2H),7.25–7.20(m,1H),7.16–7.04(m,3H),6.90(d,J=8.2Hz,2H),6.66(d,J=8.1Hz,2H),5.79(t,J=7.6Hz,1H),4.16(q,J=7.0Hz,2H),2.54(dd,J=15.0,8.3Hz,1H),2.40(dd,J=15.0,7.1Hz,1H),2.12(s,3H),1.27(t,J=7.1Hz,3H).
13C-NMR(75MHz,CDCl 3)δ169.16,142.43,133.58,133.53,133.23,132.46,129.26,129.02,129.00,128.13,127.82,127.39,127.30,127.10,126.53,126.18,126.16,123.02,122.77,60.27,55.39,39.94,20.90,13.76.
Embodiment 8
2-methyl-6-ethoxycarbonylmethyl group-5-p-toluenesulfonyl-5,6-dihydro phenanthridines (I-8) synthetic:
With (E)-2-(3-oxyethyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-3:R=OCH 2CH 3) and 4-methyl-N-(4-tosyl group)-2-bromaniline be raw material, the operation with embodiment 1, obtain faint yellow oily product I-8, productive rate 82%.
Figure BDA00003695972700062
1H-NMR(300MHz,CDCl 3)δ7.64(d,J=8.2Hz,1H),7.37(s,1H),7.25–7.15(m,2H),7.16–7.09(m,3H),6.92(d,J=8.0Hz,2H),6.67(d,J=8.0Hz,2H),5.76(t,J=7.6Hz,1H),4.16(q,J=7.1Hz,2H),2.53(dd,J=14.9,8.3Hz,1H),2.46–2.33(m,4H),2.13(s,3H),1.27(t,J=7.0Hz,3H).
13C-NMR(75MHz,CDCl 3)δ169.34,142.33,136.88,133.65,133.35,132.32,129.87,129.19,129.09,129.05,128.93,128.78,127.81,127.20,126.85,126.54,126.18,123.55,122.67,60.36,55.33,39.81,20.88,20.73,13.80.
Embodiment 9
6-ethoxycarbonylmethyl group-5,6-dihydro phenanthridines (I-9) synthetic:
With (E)-2-(3-oxyethyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-3:R=OCH 2CH 3) and the 2-bromaniline be raw material, the operation with embodiment 1, obtain white solid product I-9, productive rate 85%, 102~103 ℃ of melting ranges.
Figure BDA00003695972700071
1H-NMR(300MHz,CDCl 3)δ7.76(d,J=8.0Hz,1H),7.27(dd,J=7.9,1.26Hz,1H),7.36(td,J=7.6,1.4Hz,1H),7.26(td,J=7.4,1.2Hz,1H),7.19–7.11(m,2H),6.87(td,J=7.7,1.1Hz,1H),6.72(dd,J=7.9,0.9Hz,1H),4.86(dd,J=10.3,3.1Hz,1H),4.19(q,J=7.1Hz,2H),2.88(dd,J=16.5,10.4Hz,1H),2.45(dd,J=16.5,3.2Hz,1H),1.27(t,J=7.1Hz,3H).
13C-NMR(75MHz,CDCl 3)δ171.69,142.57,134.21,130.66,128.71,127.52,126.86,125.56,122.89,122.20,120.30,119.02,115.73,60.52,51.66,39.50,13.93.
Embodiment 10
2-methyl-6-ethoxycarbonylmethyl group-5,6-dihydro phenanthridines (I-10) synthetic:
With (E)-2-(3-oxyethyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-3:R=OCH 2CH 3) and 4-methyl-2-bromaniline be raw material, the operation with embodiment 1, obtain white solid product I-10, productive rate 85%, 140~143 ℃ of melting ranges.
Figure BDA00003695972700072
1H-NMR(300MHz,CDCl 3)δ7.73(d,J=7.7Hz,1H),7.51(s,1H),7.33(td,J=7.6,1.4Hz,1H),7.23(td,J=7.3,1.1Hz,1H),7.13(d,J=6.8Hz,1H),6.95(d,J=7.4Hz,1H),6.62(d,J=8.0Hz,1H),4.79(dd,J=10.3,3.1Hz,1H),4.16(q,J=7.1Hz,2H),2.86(dd,J=10.3,1.47Hz,1H),2.41(td,J=3.2,16.4Hz,1H),2.32(s,3H),1.25(t,J=7.2Hz,3H).
13C?NMR(75MHz,CDCl 3)δ171.94,139.82,134.13,130.79,129.34,127.69,127.42,126.74,125.50,123.20,122.11,120.33,115.49,60.01,51.91,39.32,20.35,13.80.
Embodiment 11
The fluoro-6-ethoxycarbonylmethyl group-5 of 2-, 6-dihydro phenanthridines (I-11) synthetic:
With (E)-2-(3-oxyethyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-3:R=OCH 2CH 3) and the fluoro-2-bromaniline of 4-be raw material, the operation with embodiment 1, obtain white solid product I-11, productive rate 75%, 136~138 ℃ of melting ranges.
Figure BDA00003695972700081
1H-NMR(300MHz,CDCl 3)δ7.65(d,J=7.7Hz,1H),7.39(dd,J=9.9,2.8Hz,1H),7.33(dd,J=7.6,1.3Hz,1H),7.30–7.23(m,1H),7.14(dd,J=7.4,0.8Hz,1H),6.85(td,J=8.5,2.8Hz,1H),6.63(dd,J=8.7,4.8Hz,1H),4.80(dd,J=10.4,3.0Hz,1H),4.17(q,J=7.1Hz,2H),2.83(dd,J=16.5,10.4Hz,1H),2.41(dd,J=16.5,3.1Hz,1H),1.26(t,J=7.1Hz,3H).
13C-NMR(75MHz,CDCl 3)δ171.84,158.03,134.09,127.57,127.46,125.52,122.30,116.19,116.05,115.39,115.03,109.32,109.05,60.32,51.91,39.41,13.94.
Embodiment 12
6-methoxycarbonyl methyl-5,6-dihydro phenanthridines (I-12) synthetic:
With (E)-2-(3-methoxyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-4:R=OCH 3) and the 2-bromaniline be raw material, the operation with embodiment 1, must look for oily product I-12, productive rate 72%.
1H-NMR(300MHz,CDCl 3)δ7.73(d,J=7.7Hz,1H),7.69(dd,J=7.8,1.1Hz,1H),7.33(td,J=7.6,1.3Hz,1H),7.26–7.20(m,2H),7.15–7.09(m,2H),6.84(td,J=7.5,0.8Hz,1H),6.69(d,J=7.9Hz,1H),4.82(dd,J=10.4,3.0Hz,1H),3.69(s,3H),2.87(dd,J=16.6,10.4Hz,1H),2.43(dd,J=16.7,3.1Hz,1H).
13C-NMR(75MHz,CDCl 3)δ172.19,142.33,133.84,130.80,128.71,127.56,126.72,125.56,122.94,122.21,120.43,118.65,115.61,51.67,51.15,39.50.
Embodiment 13
The fluoro-6-methoxycarbonyl of 2-methyl-5,6-dihydro phenanthridines (I-13) synthetic:
With (E)-2-(3-methoxyl group-3-oxo-1-propenyl) phenylo boric acid pinacol ester (II-4:R=OCH 3) and the fluoro-2-bromaniline of 4-be raw material, the operation with embodiment 1, obtain white solid product I-13, productive rate 67%, 101~103 ℃ of melting ranges.
1H-NMR(300MHz,CDCl 3)δ7.64(d,J=7.9Hz,1H),7.38(dd,J=9.9,2.7Hz,1H),7.33(dd,J=7.7,1.4Hz,1H),7.26(td,J=7.4,1.3Hz,1H),7.13(d,J=7.4Hz,1H),6.84(td,J=8.5,2.8Hz,1H),6.62(dd,J=8.7,4.8Hz,1H),4.80(dd,J=10.4,3.1Hz,1H),3.70(s,3H),2.84(dd,J=16.6,10.4Hz,1H),2.42(dd,J=16.6,3.1Hz,1H).
13C-NMR(75MHz,CDCl 3)δ171.92,158.06,138.21,127.61,127.49,125.51,122.37,116.21,116.16,115.39,115.09,109.36,109.05,51.75,51.19,38.97.
Embodiment 14
6-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-1) synthetic:
In the 500ml three-necked bottle, by (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) (2.72g, 0.01mol), N-(4-tosyl group)-2-bromaniline (3.24g; 0.01mol), [two (triphenyl phosphorus)] palladium chloride (0.70g, 0.001mol) and 2mol/L aqueous sodium carbonate (6.36g; 0.06mol) all be dissolved in the 300mL glycol dimethyl ether, pass into nitrogen protection, be heated to the 6h that refluxes; after TLC monitoring raw material disappears, be cooled to room temperature, filter; filtrate decompression is concentrated; the residue column chromatography for separation, obtain yellow oil product I-1, productive rate 62%.
Embodiment 15
6-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-1) synthetic:
In the 500ml three-necked bottle, by (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) (2.72g, 0.01mol), N-(4-tosyl group)-2-bromaniline (3.24g; 0.01mol), tetrakis triphenylphosphine palladium (1.16g, 0.001mol) and 2mol/L wet chemical (8.29g; 0.06mol) all be dissolved in the 300mL glycol dimethyl ether, pass into nitrogen protection, be heated to the 6h that refluxes; after TLC monitoring raw material disappears, be cooled to room temperature, filter; filtrate decompression is concentrated; the residue column chromatography for separation, obtain yellow oil product I-1, productive rate 79%.
Embodiment 16
6-(3-oxopropyl)-5-(4-tosyl group)-5,6-dihydro phenanthridines (I-1) synthetic:
In the 500ml three-necked bottle, by (E)-2-(3-oxo-1-butylene base) phenylo boric acid pinacol ester (II-1:R=CH 3) (2.72g, 0.01mol), N-(4-tosyl group)-2-bromaniline (3.24g; 0.01mol), tetrakis triphenylphosphine palladium (1.16g, 0.001mol) and 2mol/L aqueous sodium carbonate (6.36g; 0.06mol) all be dissolved in Isosorbide-5-Nitrae-dioxane of 300mL, pass into nitrogen protection; be heated to the 8h that refluxes, after TLC monitoring raw material disappears, be cooled to room temperature; filter, filtrate decompression is concentrated, the residue column chromatography for separation; obtain yellow oil product I-1, productive rate 41%.

Claims (10)

1. a 6-replaces the preparation method of-5,6-dihydro phenanthridine derivatives (I), comprising:
Figure FDA00003695972600011
Wherein: R 1Alkyl, phenyl, methoxy or ethoxy for C1~C6; R 2For hydrogen, chlorine, fluorine or methyl; R 3For hydrogen or p-toluenesulfonyl;
Catalyzer is tetrakis triphenylphosphine palladium, [1,1 '-bis-(diphenylphosphino) ferrocene] palladium chloride, [1,1 '-bis-(diphenylphosphine) ferrocene] palladium chloride methylene dichloride complex compound, two (bis-Ya Benzyl benzylacetone) palladium or [two (triphenyl phosphorus)] palladium chloride.
2. the preparation method of claim 1, wherein catalyzer is tetrakis triphenylphosphine palladium.
3. the preparation method of claim 1, wherein alkali is aqueous sodium carbonate, wet chemical, aqueous sodium hydroxide solution, potassium hydroxide aqueous solution, cesium fluoride, potassiumphosphate, N, N -Diisopropylethylamine, 1,8 -Diazabicyclo [5.4.0] 11 carbon-7-alkene or triethylamine.
4. the preparation method of claim 3, wherein alkali is aqueous sodium carbonate or wet chemical.
5. the preparation method of claim 1, wherein reaction solvent is glycol dimethyl ether, ethylene glycol diethyl ether, Isosorbide-5-Nitrae-dioxane or DMF.
6. the preparation method of claim 5, wherein reaction solvent is glycol dimethyl ether.
7. the preparation method of claim 1, wherein the molar ratio of II, III, catalyzer, alkali is 1:0.5~2:0.01~0.2:1~10.
8. the preparation method of claim 7, wherein the molar ratio of II, III, catalyzer, alkali is 1:0.9~1.1:0.05~0.1:4~8.
9. the preparation method of claim 1, wherein temperature of reaction is 50 ℃~120 ℃.
10. the preparation method of claim 9, wherein temperature of reaction is 80 ℃~110 ℃.
CN201310368105.8A 2013-08-21 2013-08-21 A kind of 6-replaces the preparation method of-5,6-dihydrophenanthridine derivatives Active CN103408492B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310368105.8A CN103408492B (en) 2013-08-21 2013-08-21 A kind of 6-replaces the preparation method of-5,6-dihydrophenanthridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310368105.8A CN103408492B (en) 2013-08-21 2013-08-21 A kind of 6-replaces the preparation method of-5,6-dihydrophenanthridine derivatives

Publications (2)

Publication Number Publication Date
CN103408492A true CN103408492A (en) 2013-11-27
CN103408492B CN103408492B (en) 2016-02-10

Family

ID=49601549

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310368105.8A Active CN103408492B (en) 2013-08-21 2013-08-21 A kind of 6-replaces the preparation method of-5,6-dihydrophenanthridine derivatives

Country Status (1)

Country Link
CN (1) CN103408492B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153032A (en) * 2015-10-13 2015-12-16 遵义医学院 Preparation method of 6-H-phenanthridine compounds by one-pot process
CN105153033A (en) * 2015-10-13 2015-12-16 遵义医学院 Preparation method of 6-H-phenanthridine compound
CN107721926A (en) * 2016-08-11 2018-02-23 重庆大学 A kind of preparation method of dihydrophenanthridine derivative
CN107778241A (en) * 2016-08-29 2018-03-09 中山大学 A kind of new synthetic method of the dihydrophenanthridine class compound of 6 aryl 5,6
CN107935925A (en) * 2017-11-22 2018-04-20 浙江大学 A kind of preparation method of polysubstituted triphenylene acridine compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1968932A (en) * 2004-06-18 2007-05-23 惠氏公司 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
US20070191583A1 (en) * 2005-12-19 2007-08-16 Josemon Jacob Polymers based on 3,6-and 2,7-conjugated poly(phenanthrene) and pled devices
CN102952073A (en) * 2011-08-17 2013-03-06 中国科学院大连化学物理研究所 Method for synthesizing dihydrogen phenanthridine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1968932A (en) * 2004-06-18 2007-05-23 惠氏公司 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
US20070191583A1 (en) * 2005-12-19 2007-08-16 Josemon Jacob Polymers based on 3,6-and 2,7-conjugated poly(phenanthrene) and pled devices
CN102952073A (en) * 2011-08-17 2013-03-06 中国科学院大连化学物理研究所 Method for synthesizing dihydrogen phenanthridine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BYUNG SEOK KIM 等: "Pd-Catalyzed Sequential C-C and C-N Bond Formations for the Synthesis of N-Heterocycles: Exploiting Protecting Group-Directed C-H Activation under Modified Reaction Conditions", 《CHEMISTRY-AN ASIAN JOURNAL》 *
晁建平 等: "对羟基苯硼酸频哪醇酯的合成", 《中国医药工业杂志》 *
杨洪勤 等: "四(三苯基膦)化钯催化的若干菲啶类化合物的合成", 《有机化学》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153032A (en) * 2015-10-13 2015-12-16 遵义医学院 Preparation method of 6-H-phenanthridine compounds by one-pot process
CN105153033A (en) * 2015-10-13 2015-12-16 遵义医学院 Preparation method of 6-H-phenanthridine compound
CN107721926A (en) * 2016-08-11 2018-02-23 重庆大学 A kind of preparation method of dihydrophenanthridine derivative
CN107778241A (en) * 2016-08-29 2018-03-09 中山大学 A kind of new synthetic method of the dihydrophenanthridine class compound of 6 aryl 5,6
CN107778241B (en) * 2016-08-29 2022-07-22 中山大学 Novel synthesis method of 6-aryl-5, 6-dihydrophenanthridine compound
CN107935925A (en) * 2017-11-22 2018-04-20 浙江大学 A kind of preparation method of polysubstituted triphenylene acridine compound
CN107935925B (en) * 2017-11-22 2020-06-19 浙江大学 Preparation method of polysubstituted phenanthridine compound

Also Published As

Publication number Publication date
CN103408492B (en) 2016-02-10

Similar Documents

Publication Publication Date Title
CN103408492A (en) Preparation method of 6-substitute-5,6-dihydro phenanthridine derivative
ES2585221T3 (en) A process for the preparation of 6- (7 - ((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -n-methyl-1-naphthamide and synthetic intermediates thereof
CN104031029A (en) Synthesis method of 2-[(-4-chlorophenyl)(4-piperidinyl-oxy)methyl]pyridine having single optical isomer
CN103435558A (en) Synthetic method of quinazoline derivative
KR20100101315A (en) Process for preparing phenanthridine derivatives using trifluoroacetic acid
TW202039476A (en) Pharmaceutical process and intermediates
CN106188044A (en) A kind of synthetic method of 3 arylthio imidazos [1,5 a] the N heterocyclic compound of catalysis of iodine
CN108484508B (en) A kind of synthetic method of 5- trifluoromethyl uracil
CN105209435A (en) Pyridine- or pyrazine-containing compounds
US20220055983A1 (en) Amine-boranes as bifunctional reagents for direct amidation of carboxylic acids
CN111875549B (en) Method for synthesizing quinazolinone compound in aqueous phase through photocatalysis
CN104418771B (en) Preparation and application of DMAP hydrochloride as catalyst of recoverable acylation reaction
Wang et al. The Synthesis of 3, 4-Disubstituted Dihydroquinolin-2 (1 H)-One Under Metal-Free Conditions in Aqueous Solution
CN103242357B (en) A kind of synthetic method of polysubstituted Silole derivative
JP2012036131A (en) Dihydroxyboryl group-containing, nitrogen-containing heterocyclic derivative, medicine comprising the derivative as active ingredient and method for producing the derivative
CN103288707B (en) A kind of preparation method of 3-benzene sulfydryl indole derivative
CN106146271A (en) A kind of method being prepared diaryl ketone by aromatic yl sulphonate
RU2016146200A (en) METHOD FOR PRODUCING ETHER (MET) OF ACRYLIC ACID AND METHOD FOR PRODUCING AROMATIC ETHER OF CARBONIC ACID
Wang et al. Generation of 6 H-benzo [f] cyclopenta [d][1, 2] thiazepine 5, 5-dioxides via a palladium-catalyzed reaction of 2-(2-alkynyl) benzenesulfonamide
CN104311528A (en) Method for preparing chromene derivative
CN105175412A (en) Synthetic method for 2-amino-1,10-phenanthroline
CN104402832A (en) Preparation method for dihydropyrimidine derivative
CN103288780A (en) Preparation method of 1-phenyl-1-cyclopentyl epoxy ethane
CN104016914B (en) A kind of preparation method of amide compound
WO2014075648A1 (en) A method of preparing apixaban

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: Tong Xiang, Gulou District of Nanjing city of Jiangsu Province, No. 24 210009

Patentee after: CHINA PHARMACEUTICAL University

Address before: 211200 Kechuang Center, 688 Tianshengqiao Avenue, Yongyang Town, Lishui County, Nanjing City, Jiangsu Province

Patentee before: CHINA PHARMACEUTICAL University